Financial Metric Page

BioXcel Therapeutics, Inc.: Quick Ratio

Latest period: Q4 2025. Period end: 31 Dec 2025. Units: x. Frequency: quarterly.

The acid-test ratio, also called the quick ratio, is a metric used to see if a company is positioned to sell assets within 90 days to meet immediate expenses.

What This Metric Tells You

  • Shows the reported level of quick ratio over 31 Dec 2022 - 31 Dec 2025.
  • Includes year-over-year change points to highlight acceleration or slowdown.
  • Built from 13 SEC fact rows for this metric and issuer.

How To Read This Chart

  • Start with the latest point, then compare it with the prior periods to see direction.
  • Use quarterly sequence to compare like-for-like periods.
  • Use YoY change bars to separate growth from contraction across matching periods.

Metric Details

Metric
Quick Ratio (QuickRatio)
Taxonomy
ratio
Units tracked
x
Frequency coverage
quarterly
History range
31 Dec 2022 - 31 Dec 2025
Facts on this page
13
Description
The acid-test ratio, also called the quick ratio, is a metric used to see if a company is positioned to sell assets within 90 days to meet immediate expenses.
Metric-level SEC endpoint
Open SEC company concept

Chart Context

Compare periods with the same frequency first, then use YoY and TTM series to confirm whether changes are structural or one-off.

Quick Ratio, Quarterly (x)
Quick Ratio, YoY Quarterly Change (%)

BioXcel Therapeutics, Inc. Quarterly Quick Ratio (x)

Period Value YoY Chg Change % Date
Q4 2025 0.02x -0.05x -78% 31 Dec 2025
Q3 2025 0.02x -0.06x -75% 30 Sep 2025
Q2 2025 0.03x -0.04x -57% 30 Jun 2025
Q1 2025 0.05x -0.01x -13% 31 Mar 2025
Q4 2024 0.07x +0.01x +13% 31 Dec 2024
Q3 2024 0.08x +0.02x +33% 30 Sep 2024
Q2 2024 0.07x +0.01x +20% 30 Jun 2024
Q1 2024 0.06x -0x -1.8% 31 Mar 2024
Q4 2023 0.06x +0x +2.2% 31 Dec 2023
Q3 2023 0.06x 30 Sep 2023
Q2 2023 0.06x 30 Jun 2023
Q1 2023 0.06x 31 Mar 2023
Q4 2022 0.06x 31 Dec 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.

Sponsored